Facial recognition technology confirms Hollywood is getting more diverse
Science & Technology

Facial recognition technology confirms Hollywood is getting more diverse

Technology tamfitronics Technology tamfitronics Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation!Press and hold the buttonIf you believe this is an error, please contact our support team.2a0d:f302:121:678::1 :b4b91b94-2cd1-49aa-9dc8-2a28f26a
Continue reading
American chip equipment makers are cutting off China
Science & Technology

American chip equipment makers are cutting off China

Technology tamfitronics In This StoryAs the U.S. continues to strengthen restrictions on advanced technology in China, U.S.-based chip equipment manufacturers are reportedly telling suppliers to find alternatives to Chinese-made components.Suggested ReadingThe 'smart money' predicts a Donald Trump win and a Republican landslide, strategist saysSuggested ReadingChip equipment makers, including California-based Applied Materials (HUGE-0.83%) and Lam Research (LRCX-0.80%), have told suppliers they worry risking their vendor status for using certain components supplied by China, the Wall Street Journal reported, citing unnamed people familiar with the matter. The companies have also told suppliers not to have Chinese investors or shareholders,...
Continue reading
Site-specific drug release of monomethyl fumarate to treat oxidative stress disorders
Science & Technology

Site-specific drug release of monomethyl fumarate to treat oxidative stress disorders

Technology tamfitronics MainThe transcription factor nuclear factor E2-related factor 2 (NRF2) is an attractive therapeutic target because its activation stimulates a panoply of antioxidants that naturally resolve oxidative stress, a process central to diseases with great societal burden1,2,3,4. However, systemically distributed activators such as monomethyl fumarate (MMF) have global on-target actions because of the ubiquitous expression of NRF2 (refs. 2,3,5,6). In addition to activating NRF2 by modifying Kelch-like ECH-associated protein 1 (KEAP1) thiols (Cys151), MMF also exerts undesirable off-target actions by indiscriminately modifying other protein thiols as well3,4,5,6,7,8. We sought to overcome these dose-limiting and harmful side effects3,4,5,6,9,10 by creating a prodrug that would release MMF only when and where required.Hydrogen peroxide and peroxynitrite are...
Continue reading